United States · FDA National Drug Code directory
Synthroid
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0074-6594_b85ab7fa-ba96-43cd-b736-44b3924e644c
- Product NDC
- 0074-6594
- Form
- TABLET
- Composition / generic term
- Levothyroxine Sodium
- Labeler
- AbbVie Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20020724
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOTHYROXINE SODIUM — 88 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET in 1 BOTTLE (0074-6594-19) · 0074-6594-19
- 2 BLISTER PACK in 1 CARTON (0074-6594-72) / 7 TABLET in 1 BLISTER PACK · 0074-6594-72
- 90 TABLET in 1 BOTTLE (0074-6594-90) · 0074-6594-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →